MEDICA 2022, Düsseldorf, Germany
14-17/11/2022
News & Events
Health Plus Care 2022, ExCeL LONDON
18-19/5/2022
Digital Healthcare Show
Vietnam Medi Pharm 2022 Hanoi
11-14/5/2022
The 29th Vietnam Int’l Medical and Pharmaceutical
Biomed Israel 2022
10-12/5/2022
The 20th National Life Science & Technology Event
CardiacSense’s medical watch monitors heart rate and arrhythmias. Its next project? Preventing the next heart attack
30.07.2021
CardiacSense announced that it received the CE Mark for marketing & sales of the CardiacSense medical watch in the European Union
10.02.2021
CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation
10.02.2021
A New, Data-Led Era for Cardiology
11/01/2021
Patients can now be monitored continuously and extensively at home, reducing hospitalization and saving healthcare expenditure…
Heart Monitoring Made Accurate on the Go
4/01/2021
Eldad Shemesh, CardiacSense Funder & CEO on Keeping Time to Market during COVID
CardiacSense signs $32.4m medical watch Indian deal
7.6.2020
בלעדי ל-Techtime: קרדיאק-סנס מייצרת 100 אלף שעונים רפואיים
14.05.2020
Several Telemedicine and Remote-Patient Monitoring Solutions Cutting Through the COVID-19 Clutter
11.04.2020
In a time of social distancing and isolation, technology is enabling patients, caregivers, and clinicians to communicate and monitor health remotely.
CardiacSense has developed a wearable for continuously monitoring vital signs of either inpatients or outpatients.
CardiacSense Medical Grade Watch receives CE Mark for continuous detection of Atrial Fibrillation
10.02.2021
The watch will begin shipping in EU as a medical device for continuous…
The CardiacSense medical watch receives the Israeli Ministry of Health’s regulatory approval
6.8.2020
This is the first medical wristwatch to receive medical regulatory approval for beat by beat heart rate monitoring and A-Fib detection with ECG accuracy
CardiacSense doubles orders for its wearable medical watch with a $32.4 million contract in India
7.6.2020
The agreement was signed with a distributor for the company’s product, which monitors detects fever, respiratory and chronic diseases as well as heart arrhythmias at a uniquely precise level of an ECG device
CadiacSense unveils Its business model towards beginning of sales in 2020
26.05.2020
The Company will enable patients to benefit from Cloud-based medical monitoring, on a monthly fee
HSC Partners with CardiacSense for medical-grade wearables
24.04.2020
CardiacSense is a leading manufacturer of a range of wearable devices for the continuous monitoring of heart arrhythmias and blood pressure